Olga Mitina

Dual-specific Src and Abl kinase inhibitors, PP1 and CGP76030, inhibit growth and survival of cells expressing imatinib mesylate–resistant Bcr-Abl kinases

Markus Warmuth, Nicola Simon, Olga Mitina et al. · Blood · 2002 · 135 citations · Full text

Detection of Peptides, Proteins, and Drugs That Selectively Interact With Protein Targets

Ilya G. Serebriiskii, Olga Mitina, Elena N. Pugacheva et al. · Genome Research · 2002 · 38 citations · Full text

Inhibition of IL-6-dependent growth of myeloma cells by an acidic peptide repressing the gp130-mediated activation of Src family kinases

Amparo Hausherr, Rosário Tavares, Michael Schäffer et al. · Oncogene · 2007 · 24 citations

Hematological Malignancy, Immunology, Myeloma Cells +8

Role of p21WAF1/CIP1 as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells

Karin Forster, Axel Obermeier, Olga Mitina et al. · Annals of Hematology · 2007 · 15 citations

Hematological Malignancy, Tumor Biology, Bcr-abl-transformed Hematopoietic Cells +10

Two-hybrid dual bait system to discriminate specificity of protein interactions in small GTPases

Ilya G. Serebriiskii, Olga Mitina, Jonathan Chernoff et al. · Methods in enzymology on CD-ROM/Methods in enzymology · 2001 · 14 citations

Biology, Protein Function, Protein Expression +14